Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective
Nephropathic cystinosis (NC) is a rare lysosomal disease, leading to early kidney failure and extra-renal comorbidities. Its prognosis strongly relies on early diagnosis and treatment by cysteamine. Developing economies (DEing) face many challenges when treating patients for rare and chronic disease...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 2024
|
| In: |
Pediatric nephrology
Year: 2024, Volume: 39, Issue: 4, Pages: 1113-1123 |
| ISSN: | 1432-198X |
| DOI: | 10.1007/s00467-023-06179-3 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00467-023-06179-3 |
| Author Notes: | Maitena Regnier, Sacha Flammier, Mounia Boutaba, Aliou Abdoulaye Ndongo, Aude Servais, Franz Schaefer, Elena Levtchenko, Justine Bacchetta, Aurélia Bertholet-Thomas |
| Summary: | Nephropathic cystinosis (NC) is a rare lysosomal disease, leading to early kidney failure and extra-renal comorbidities. Its prognosis strongly relies on early diagnosis and treatment by cysteamine. Developing economies (DEing) face many challenges when treating patients for rare and chronic diseases. The aim here is to evaluate the access to investigations and treatment in DEing, and to assess for potential inequalities with Developed Economies (DEed). |
|---|---|
| Item Description: | Online veröffentlicht am 18. November 2023 Gesehen am 11.03.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1432-198X |
| DOI: | 10.1007/s00467-023-06179-3 |